These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6318542)

  • 1. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    Am J Cardiol; 1984 Jan; 53(1):105-8. PubMed ID: 6318542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy from systemic hypertension by enalapril.
    Nakashima Y; Fouad FM; Tarazi RC
    Am J Cardiol; 1984 Apr; 53(8):1044-9. PubMed ID: 6322566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
    Ribstein J; Du Cailar G; Brouard R; Mimran A
    Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Cardiol; 1988 Nov; 62(13):912-6. PubMed ID: 2845768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension.
    Navis GJ; de Jong PE; Donker AJ; de Zeeuw D
    Proc Eur Dial Transplant Assoc; 1983; 20():577-81. PubMed ID: 6318224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of converting enzyme inhibition by enalapril on renal hemodynamics in essential arterial hypertension].
    Chaignon M; Moreau L
    Presse Med; 1988 Oct; 17(34):1745-7. PubMed ID: 2855543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
    DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
    J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension.
    Ventura HO; Frohlich ED; Messerli FH; Kobrin I; Kardon MB
    Am J Cardiol; 1985 Apr; 55(8):1023-6. PubMed ID: 2984914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
    Haznedaroglu IC; Erdem Y; Tokgözoglu L; Caglar M; Kes S; Sayinalp NM; Yörükan S
    Cent Afr J Med; 1995 Apr; 41(4):118-23. PubMed ID: 7788682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate hemodynamic effects of urapidil in patients with essential hypertension.
    Kobrin I; Amodeo C; Ventura HO; Messerli FH; Frohlich ED
    Am J Cardiol; 1985 Mar; 55(6):722-5. PubMed ID: 3976516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and subacute haemodynamic effects of enalapril. Non-invasive studies of a new converting enzyme inhibitor for antihypertensive treatment.
    Wikstrand J; Herlitz H; Berglund G
    Scand J Urol Nephrol Suppl; 1984; 79():81-5. PubMed ID: 6089322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.